| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.0068 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |